Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Work In Process (2017 - 2023)

Perspective Therapeutics (CATX) has disclosed Work In Process for 11 consecutive years, with $616000.0 as the latest value for Q1 2023.

  • Quarterly Work In Process rose 73.52% to $616000.0 in Q1 2023 from the year-ago period, while the trailing twelve-month figure was $616000.0 through Mar 2023, up 73.52% year-over-year, with the annual reading at $636000.0 for FY2022, N/A changed from the prior year.
  • Work In Process hit $616000.0 in Q1 2023 for Perspective Therapeutics, down from $636000.0 in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $636000.0 in Q4 2022 to a low of $114000.0 in Q1 2019.
  • Historically, Work In Process has averaged $306000.0 across 5 years, with a median of $240000.0 in 2020.
  • Biggest five-year swings in Work In Process: fell 25.49% in 2019 and later skyrocketed 129.1% in 2022.
  • Year by year, Work In Process stood at $166000.0 in 2019, then increased by 26.51% to $210000.0 in 2020, then surged by 37.14% to $288000.0 in 2021, then soared by 120.83% to $636000.0 in 2022, then dropped by 3.14% to $616000.0 in 2023.
  • Business Quant data shows Work In Process for CATX at $616000.0 in Q1 2023, $636000.0 in Q4 2022, and $614000.0 in Q3 2022.